| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,685 |
9,427 |
$419K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,115 |
8,443 |
$233K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,118 |
1,615 |
$171K |
| J0897 |
Injection, denosumab, 1 mg |
223 |
200 |
$101K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,775 |
929 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,457 |
5,211 |
$35K |
| 96367 |
|
1,561 |
773 |
$33K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
991 |
513 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,821 |
8,677 |
$21K |
| 96417 |
|
518 |
285 |
$20K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,536 |
780 |
$18K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
165 |
107 |
$18K |
| J1756 |
Injection, iron sucrose, 1 mg |
578 |
248 |
$14K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
61 |
36 |
$5K |
| 99442 |
|
221 |
213 |
$4K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
35 |
29 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
58 |
58 |
$4K |
| 96415 |
|
103 |
65 |
$3K |
| 99215 |
Prolong outpt/office vis |
53 |
49 |
$3K |
| 99443 |
|
51 |
46 |
$3K |
| 99205 |
Prolong outpt/office vis |
39 |
39 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
4,092 |
3,870 |
$2K |
| J9045 |
Injection, carboplatin, 50 mg |
121 |
56 |
$1K |
| 96368 |
|
76 |
42 |
$922.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,783 |
831 |
$698.80 |
| 96401 |
|
14 |
12 |
$483.39 |
| 96402 |
|
36 |
30 |
$416.99 |
| 36415 |
Collection of venous blood by venipuncture |
1,542 |
1,306 |
$401.26 |
| 99441 |
|
14 |
14 |
$314.42 |
| 99497 |
|
15 |
14 |
$250.27 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
17 |
12 |
$238.19 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
23 |
16 |
$227.57 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
161 |
100 |
$152.86 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
287 |
155 |
$132.61 |
| 81000 |
|
88 |
67 |
$111.62 |
| J3490 |
Unclassified drugs |
208 |
107 |
$107.08 |
| J3480 |
Injection, potassium chloride, per 2 meq |
121 |
75 |
$90.93 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
123 |
77 |
$42.55 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
387 |
373 |
$0.00 |